MetaCap

Glaukos Earnings

NYSE: GKOSHealth CareMedical/Dental InstrumentsUSD

165.69+4.40 (+2.73%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Oct 28, 2026

After market close

Fiscal period

Sep/2026

EPS estimate

$-0.12

Glaukos earnings summary

Glaukos is scheduled to report Sep/2026 earnings on Oct 28, 2026 after the market closes, with analysts expecting EPS of $-0.12. In its most recent report on Jul 29, 2026 (Q2 2026), GKOS posted EPS of $-0.31. Revenue for the quarter was $185.6 million.

Across the last 16 reports, GKOS shares moved an average of 5.5% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.

Summary generated from market data by MetaCap's automated system. Methodology

GKOS earnings history

Glaukos reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 29, 2026—$-0.31—+8.0%
Apr 30, 2026—$-0.34—-4.8%
Feb 23, 2026—$-2.34—-10.5%
Oct 31, 2025—$-0.28—-4.8%
Aug 4, 2025—$-0.34—+6.2%
May 1, 2025—$-0.32—+2.7%
Feb 25, 2025—$-0.56—-13.2%
Nov 5, 2024—$-0.39—-2.3%
Aug 2, 2024—$-1.00—+4.8%
May 3, 2024—$-0.82—+3.7%
Feb 23, 2024—$-0.75—-0.8%
Nov 1, 2023—$-0.63—-5.7%
Aug 2, 2023—$-0.68—-0.0%
May 4, 2023—$-0.72—+7.9%
Feb 24, 2023—$-0.66—+5.8%
Nov 4, 2022—$-0.58—+6.8%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related